Frevecitinib Clinical Trials (2026): 1 Studies for Severe Asthma
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Frevecitinib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Severe Asthma) and 512 total planned enrollment. 1 Frevecitinib clinical trial is actively recruiting. Most recent activity: NCT07532265 (Nov 2027).
Frevecitinib clinical trials at a glance: phase × recruitment status
| Phase | not yet recruiting | Total |
|---|---|---|
| P2 | 1 | 1 |
Recruiting Frevecitinib clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07532265 | PANAIRAMAA Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma | P2 | Severe Asthma | 512 | Jun 2026 |
Frevecitinib pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| PANAIRAMA | NCT07532265 | P2 | not yet recruiting | Severe Asthma | 512 | — |
All Frevecitinib trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07532265 | PANAIRAMA | A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma | P2 | not yet recruiting | 512 | Kinaset Therapeutics Inc | Jun 2026 |
Frevecitinib clinical trials: frequently asked questions
- How many Frevecitinib clinical trials are there?
- 1 Frevecitinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are Frevecitinib clinical trials recruiting in 2026?
- No active Frevecitinib trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is Frevecitinib being studied for?
- Frevecitinib is being studied for Severe Asthma. The trials are grouped by indication on this page.
- What phase is Frevecitinib in?
- Frevecitinib clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Frevecitinib clinical trials?
- The lead sponsor across the most Frevecitinib trials is Kinaset Therapeutics Inc. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Frevecitinibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: